Source comparison
PE-22-28 vs Selank Amidate: Research Application Comparison
PE-22-28 BDNF upregulation via gp130/JAK-STAT3 pathway; promotes synaptic remodeling and hippocampal neurogenesis 10–14 days to measurable effect; peak at 14–16 days 0.8–1.6 mg/kg every 48–72 hours Long-term cognitive enhancement models, neuroplasticity studie
This comparison does not assign a generated winner or score.
- PE-22-28
- BDNF upregulation via gp130/JAK-STAT3 pathway; promotes synaptic remodeling and hippocampal neurogenesis
- 10–14 days to measurable effect; peak at 14–16 days
- 0.8–1.6 mg/kg every 48–72 hours
- Long-term cognitive enhancement models, neuroplasticity studies, neuroprotection research, neurodegeneration models
- 14 days refrigerated; highly temperature-sensitive
- Best for protocols requiring structural neural changes and sustained cognitive improvement over weeks
- Selank Amidate
- Enkephalin degradation inhibition; GABAergic modulation; HPA axis dampening
- 48–72 hours to behavioral effect; plateau by day 5–7
- 50–100 mcg/kg once daily
- Acute stress response models, anxiety behavior studies, short-term cognitive performance under stress
- 28–30 days refrigerated; more stable than PE-22-28
- Best for acute anxiolytic research and stress resilience testing without structural neural modification
- The table underscores the core tradeoff: PE-22-28 is a tool for investigating long-term neural adaptation. How the brain structurally reorganizes in response to sustained neurotrophin signaling. Selank Amidate is a tool for examining how acute stress response modulation affects behavior and cognition without changing baseline neural architecture. Real Peptides supplies both peptides at >98% purity with third-party verification, which is critical when comparing research outcomes across labs. Batch-to-batch variability in peptide synthesis can alter dose-response curves by 15–20%.